CZ20012713A3 - Způsob přípravy pyrazol[4,3-d]pyrimidin-7-onových sloučenin a jejich meziprodukty - Google Patents

Způsob přípravy pyrazol[4,3-d]pyrimidin-7-onových sloučenin a jejich meziprodukty Download PDF

Info

Publication number
CZ20012713A3
CZ20012713A3 CZ20012713A CZ20012713A CZ20012713A3 CZ 20012713 A3 CZ20012713 A3 CZ 20012713A3 CZ 20012713 A CZ20012713 A CZ 20012713A CZ 20012713 A CZ20012713 A CZ 20012713A CZ 20012713 A3 CZ20012713 A3 CZ 20012713A3
Authority
CZ
Czechia
Prior art keywords
lower alkyl
group
formula
compound
halogen
Prior art date
Application number
CZ20012713A
Other languages
Czech (cs)
English (en)
Inventor
Charlotte Moira Norfor Allerton
Christopher Gordon Barber
Keith Michael Devries
Laurence James Harris
Philip Charles Levett
Graham MAW
Joanna Teresa Negri
David James Rawson
Albert Shaw Wood
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018660A external-priority patent/GB0018660D0/en
Priority claimed from GB0107526A external-priority patent/GB0107526D0/en
Priority claimed from GB0110251A external-priority patent/GB0110251D0/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of CZ20012713A3 publication Critical patent/CZ20012713A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CZ20012713A 2000-07-28 2001-07-25 Způsob přípravy pyrazol[4,3-d]pyrimidin-7-onových sloučenin a jejich meziprodukty CZ20012713A3 (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0018660A GB0018660D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds
GB0107526A GB0107526D0 (en) 2001-03-26 2001-03-26 Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-one compounds and intermediates thereof
GB0110251A GB0110251D0 (en) 2001-04-26 2001-04-26 Process for the preparation of pyrazolo[4,4-d]Pyrimidin-7-one compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
CZ20012713A3 true CZ20012713A3 (cs) 2002-04-17

Family

ID=27255823

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20012713A CZ20012713A3 (cs) 2000-07-28 2001-07-25 Způsob přípravy pyrazol[4,3-d]pyrimidin-7-onových sloučenin a jejich meziprodukty

Country Status (17)

Country Link
EP (1) EP1176147A1 (enExample)
JP (1) JP2002105076A (enExample)
KR (1) KR20020010102A (enExample)
CN (1) CN1335317A (enExample)
AR (1) AR035650A1 (enExample)
AU (1) AU754962B2 (enExample)
BR (1) BR0103072A (enExample)
CA (1) CA2354175A1 (enExample)
CZ (1) CZ20012713A3 (enExample)
HK (1) HK1040715A1 (enExample)
HU (1) HUP0103075A3 (enExample)
IL (1) IL144516A0 (enExample)
IN (1) IN191315B (enExample)
MX (1) MXPA01007676A (enExample)
PL (1) PL348935A1 (enExample)
RU (1) RU2224759C2 (enExample)
YU (1) YU51701A (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6831074B2 (en) 2001-03-16 2004-12-14 Pfizer Inc Pharmaceutically active compounds
GB0106631D0 (en) * 2001-03-16 2001-05-09 Pfizer Ltd Pharmaceutically active compounds
DK1620437T3 (da) 2003-04-29 2009-08-24 Pfizer Ltd 5,7-diaminopyrazolo-4,3-d-pyrimidiner, der er anvendelige til behandling af hypertension
JP2006219373A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するピリジニルピラゾロピリミジノン誘導体
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
ES2317209T3 (es) 2004-04-07 2009-04-16 Pfizer Inc. Pirazolo(4,3-) pirimidinas.
ATE464289T1 (de) * 2005-11-16 2010-04-15 Hoffmann La Roche Neues verfahren zur herstellung von thoc
WO2007107733A1 (en) * 2006-03-17 2007-09-27 Cipla Limited Synthesis of 4-[1-(4-cyano phenyl)-(1,2,4-tr1azol-1-yl)methyl] benzonitrile and 4-[1-(1h-1,2,4-triazol-1-yl)methylene benzonitrile intermediate
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
US8183381B2 (en) 2007-07-19 2012-05-22 Metabolex Inc. N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
EP2483281B1 (en) 2009-10-01 2014-06-04 Cymabay Therapeutics, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
WO2011163090A1 (en) 2010-06-23 2011-12-29 Metabolex, Inc. Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
AU2017305392A1 (en) 2016-08-03 2019-02-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2089971A (en) * 1937-08-17 Condensation products of
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
GB9822238D0 (en) * 1998-10-12 1998-12-09 Pfizer Ltd Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
NZ517324A (en) * 1999-10-11 2003-09-26 Pfizer 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-YL)- dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors

Also Published As

Publication number Publication date
AR035650A1 (es) 2004-06-23
IL144516A0 (en) 2002-05-23
YU51701A (sh) 2003-12-31
JP2002105076A (ja) 2002-04-10
BR0103072A (pt) 2002-04-09
CN1335317A (zh) 2002-02-13
MXPA01007676A (es) 2002-10-23
HK1040715A1 (zh) 2002-06-21
AU754962B2 (en) 2002-11-28
KR20020010102A (ko) 2002-02-02
HU0103075D0 (en) 2001-10-28
HUP0103075A3 (en) 2003-04-28
CA2354175A1 (en) 2002-01-28
RU2224759C2 (ru) 2004-02-27
IN191315B (enExample) 2003-11-22
EP1176147A1 (en) 2002-01-30
HUP0103075A2 (hu) 2002-07-29
PL348935A1 (en) 2002-02-11
AU5767201A (en) 2002-01-31

Similar Documents

Publication Publication Date Title
RS59100B1 (sr) Antitela usmerena protiv her-3 i njihove upotrebe
TW513418B (en) Thiazole derivatives, their production and use
CZ281316B6 (cs) Pyrazolopyrimidinonové sloučeniny, způsob jejich přípravy a použití
SK283893B6 (sk) Spôsob výroby 5-[2-etoxy-5-(4-metylpiperazin-1-ylsulfonyl)- fenyl]-1-metyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]- pyrimidin-7-ónu a medziprodukty tohto spôsobu
CZ20012713A3 (cs) Způsob přípravy pyrazol[4,3-d]pyrimidin-7-onových sloučenin a jejich meziprodukty
JP2006527769A (ja) Ｃｂ１モジュレーターとしての２，３位置換５，６−ジアリール−ピラジン誘導体
JP2000159770A (ja) 成長ホルモン分泌促進物質の製造及び中間体
KR100525698B1 (ko) 피라졸로피리미디논의 제조 방법
CA2585557C (en) Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors
KR100395718B1 (ko) 피라졸로[4,3-ｄ]피리미딘-7-온-3-피리딜술포닐 화합물 및그의 중간체의 제조 방법
US6809200B2 (en) Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
JP4616770B2 (ja) 選択的なアミノ置換基導入法
MXPA99010795A (en) Procedure and intermediaries to obtain secretagogos of the hormone of the growth
HK1139655B (en) Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
MX2007013892A (es) Proceso para la preparacion de 5-alquiltioalquilamino-1-fenil- pirazoles.
WO2014069626A1 (ja) ピリミドジアゼピノン化合物の製造方法
HK1139655A1 (en) Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
MXPA99009326A (en) Procedure for the preparation of pirazolo [4,3-d] pyrimidin-7-onas and its intermed
HK1103724B (en) Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists